Table of Contents
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Bronchodilators Market, by Drug Type
1.1.2. Global Bronchodilators Market, by Disease
1.1.3. Global Bronchodilators Market, by Mode of Action
1.1.4. Global Bronchodilators Market, by Route of Administration
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.5. Breakdown of Primary Respondents
3.6. Forecasting Techniques
3.7. Research Methodology for Market Size Estimation
3.8. Bottom-Up Approach
3.9. Top-Down Approach
3.10. Data Triangulation
3.11. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.2.1. R&D and Designing
5.2.2. Manufacturing
5.2.3. Distribution & Sales
5.2.4. Post Sales Services
6. GLOBAL BRONCHODILATORS MARKET, BY DRUG TYPE
6.1. Overview
6.2. Adrenergic drugs
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Anticholinergics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Phosphodiesterase Inhibitor
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.5. Combination Drugs
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL BRONCHODILATORS MARKET, BY DISEASE
7.1. Overview
7.2. Asthma
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.3. COPD
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8. GLOBAL BRONCHODILATORS MARKET, BY MODE OF ACTION
8.1. Overview
8.2. Long-Acting Bronchodilators
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Short-Acting Bronchodilators
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION
9.1. Overview
9.2. Oral
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9.3. Parenteral
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
10. GLOBAL BRONCHODILATORS MARKET, BY REGION
10.1. Overview
10.2. Americas
10.2.1. North America
10.2.1.1. US
10.2.1.2. Canada
10.2.2. Latin America
10.3. Europe
10.3.1. Western Europe
10.3.1.1. Germany
10.3.1.2. France
10.3.1.3. Italy
10.3.1.4. Spain
10.3.1.5. UK
10.3.1.6. Rest of Western Europe
10.3.2. Eastern Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle East & Africa
10.5.1. Middle East
10.5.2. Africa
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitor Dashboard
11.3. Major Growth Strategy in the Global Bronchodilators Market
11.4. Competitive Benchmarking
11.5. The Leading Player in terms of Number of Developments in the Global Bronchodilators Market
11.6. Key Developments & Growth Strategies
11.7. Major Players Financial Matrix & Market Ratio
12. COMPANY PROFILES
12.1. GlaxoSmithKline
12.1.1. Company Overview
12.1.2. Drugs/Services Offered
12.1.3. Financial Overview
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Novartis AG
12.3. Merck & Co., Inc.
12.4. Abbott Laboratories
12.5. Boehringer Ingelheim GmbH
12.6. AstraZeneca plc
12.7. F. Hoffmann LA-Roche AG
12.8. Teva Pharmaceutical
12.9. Pfizer Inc.
12.10. Others
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL BRONCHODILATORS MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL BRONCHODILATORS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 7 GLOBAL BRONCHODILATORS MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 10 NORTH AMERICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 11 NORTH AMERICA BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 12 US: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 13 US: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 14 US: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 15 US: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 16 CANADA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 17 CANADA: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 18 CANADA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 19 CANADA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 20 LATIN AMERICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 21 LATIN AMERICA: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 22 LATIN AMERICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 23 LATIN AMERICA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 24 EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 25 EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 26 EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 27 EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 28 WESTERN EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 29 WESTERN EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 30 WESTERN EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 31 WESTERN EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 32 EASTERN EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 33 EASTERN EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 34 EASTERN EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 35 EASTERN EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 36 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 37 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 38 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 39 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)
TABLE 40
TABLE 41 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY DISEASE, 2020-2027 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2020-2027 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2020-2027 (USD MILLION)  
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BRONCHODILATORS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BRONCHODILATORS MARKET
FIGURE 4 GLOBAL BRONCHODILATORS MARKET SHARE, BY DRUG TYPE, 2020 (%)
FIGURE 5 GLOBAL BRONCHODILATORS MARKET SHARE, BY DISEASE, 2020 (%)
FIGURE 6 GLOBAL BRONCHODILATORS MARKET SHARE, BY MODE OF ACTION, 2020 (%)
FIGURE 7 GLOBAL BRONCHODILATORS MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2020 (%)
FIGURE 8 GLOBAL BRONCHODILATORS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 9 AMERICAS: BRONCHODILATORS MARKET SHARE BY REGION, 2020 (%)
FIGURE 10 NORTH AMERICA: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 11 EUROPE: BRONCHODILATORS MARKET SHARE, BY REGION, 2020 (%)
FIGURE 12 WESTERN EUROPE: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 13 ASIA-PACIFIC: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 14 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2020 (%)
FIGURE 15 GLOBAL BRONCHODILATORS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
FIGURE 16 GLAXOSMITHKLINE PLC: KEY FINANCIALS
FIGURE 17 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE
FIGURE 18 GLAXOSMITHKLINE PLC: REGIONAL REVENUE
FIGURE 19 NOVARTIS AG: KEY FINANCIALS
FIGURE 20 NOVARTIS AG: SEGMENTAL REVENUE
FIGURE 21 NOVARTIS AG: REGIONAL REVENUE
FIGURE 22 MERCK: KEY FINANCIALS
FIGURE 23 MERCK: SEGMENTAL REVENUE
FIGURE 24 MERCK: REGIONAL REVENUE
FIGURE 25 ABBOTT: KEY FINANCIALS
FIGURE 26 ABBOTT: SEGMENTAL REVENUE
FIGURE 27 ABBOTT.: REGIONAL REVENUE
FIGURE 28 BOEHRINGER INGELHEIM GMBH: KEY FINANCIALS
FIGURE 29 BOEHRINGER INGELHEIM GMBH: SEGMENTAL REVENUE
FIGURE 30 BOEHRINGER INGELHEIM GMBH: REGIONAL REVENUE
FIGURE 31 ASTRAZENECA: KEY FINANCIALS
FIGURE 32 ASTRAZENECA: SEGMENTAL REVENUE
FIGURE 33 ASTRAZENECA: REGIONAL REVENUE
FIGURE 34 F. HOFFMANN-LA ROCHE AG: KEY FINANCIALS
FIGURE 35 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE
FIGURE 36 F. HOFFMANN-LA ROCHE AG: REGIONAL REVENUE
FIGURE 37 TEVA PHARMACEUTICAL: KEY FINANCIALS
FIGURE 38 TEVA PHARMACEUTICAL: SEGMENTAL REVENUE
FIGURE 39 TEVA PHARMACEUTICAL: REGIONAL REVENUE
FIGURE 40 PFIZER.: KEY FINANCIALS
FIGURE 41 PFIZER.: SEGMENTAL REVENUE
FIGURE 42 PFIZER.: REGIONAL REVENUE